| Literature DB >> 25404730 |
Yang Ou1, Shang-Jui Wang1, Le Jiang1, Bin Zheng2, Wei Gu3.
Abstract
Although p53 is frequently mutated in human cancers, about 80% of human melanomas retain wild-type p53. Here we report that PHGDH, the key metabolic enzyme that catalyzes the rate-limiting step of the serine biosynthesis pathway, is a target of p53 in human melanoma cells. p53 suppresses PHGDH expression and inhibits de novo serine biosynthesis. Notably, upon serine starvation, p53-mediated cell death is enhanced dramatically in response to Nutlin-3 treatment. Moreover, PHGDH has been found recently to be amplified frequently in human melanomas. We found that PHGDH overexpression significantly suppresses the apoptotic response, whereas RNAi-mediated knockdown of endogenous PHGDH promotes apoptosis under the same treatment. These results demonstrate an important role of p53 in regulating the serine biosynthesis pathway through suppressing PHGDH expression and reveal serine deprivation as a novel approach to sensitize p53-mediated apoptotic responses in human melanoma cells.Entities:
Keywords: Apoptosis; Cancer Biology; Cell Death; Melanoma; Metabolism; Tumor Suppressor Gene; p53
Mesh:
Substances:
Year: 2014 PMID: 25404730 PMCID: PMC4281747 DOI: 10.1074/jbc.M114.616359
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157